[go: up one dir, main page]

AR049446A1 - Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados - Google Patents

Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados

Info

Publication number
AR049446A1
AR049446A1 ARP050102504A ARP050102504A AR049446A1 AR 049446 A1 AR049446 A1 AR 049446A1 AR P050102504 A ARP050102504 A AR P050102504A AR P050102504 A ARP050102504 A AR P050102504A AR 049446 A1 AR049446 A1 AR 049446A1
Authority
AR
Argentina
Prior art keywords
formula
cycloalkyl
compound
salt
alkyl
Prior art date
Application number
ARP050102504A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049446(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR049446A1 publication Critical patent/AR049446A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12—Formation of amino and carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reinvidicacion 1: Un método para preparar un compuesto de formula (1), o un complejo, sal, solvato o hidrato de éste aceptable desde un punto de vista farmacéutico, en el que R1 y R2 son diferentes y cada uno se selecciona de manera independiente de átomo de hidrogeno, alquilo C1-12, cicloalquilo C3-12, y cicloalquilo C3-12 sustituido, método que comprende: (a) hacer reaccionar un comuesto de formula (2), o una sal de éste, con un ácido y agua para rendir el compuesto de formula (1) o una sal de éste; y (b) opcionalmente convertir el compuesto de formula (1) o una sal de éste en un complejo, sal, solvato o hidrato aceptable desde un punto de vista farmacéutico, en el que R1 y R2 en la formula (2) son como se han definido en la formula (1) Reivindicacion 8: Un compuesto de formula (3), incluyendo sales de éste, en el que R1 y R2 son diferentes y cada uno se selecciona de manera independiente de átomo de hidrogeno, alquilo C1-12, cicloalquilo C3-12, y cicloalquilo C3-12 sustituido, siempre que cuando uno de los sustituyentes representados por R1 o R2 es un átomo de hidrogeno, el otro sustituyente no es metilo; y R5 y R6 se seleccionan de manera independiente de átomo de hidrogeno, alquilo C1-12, cicloalquilo C3-12, o aril-alquilo C1-6, siempre que R5 y R6 sean diferentes si no son los dos átomos de hidrogeno.
ARP050102504A 2004-06-21 2005-06-17 Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados AR049446A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58167104P 2004-06-21 2004-06-21
US62903404P 2004-11-18 2004-11-18

Publications (1)

Publication Number Publication Date
AR049446A1 true AR049446A1 (es) 2006-08-02

Family

ID=35295367

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102504A AR049446A1 (es) 2004-06-21 2005-06-17 Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados

Country Status (33)

Country Link
US (4) US20050283023A1 (es)
EP (1) EP1831154B1 (es)
JP (5) JP4174551B2 (es)
KR (3) KR100847929B1 (es)
CN (2) CN1972904B (es)
AP (1) AP2466A (es)
AR (1) AR049446A1 (es)
AT (1) ATE455093T1 (es)
AU (1) AU2005256945B2 (es)
BR (1) BRPI0512347B8 (es)
CA (1) CA2571040C (es)
CR (2) CR8765A (es)
CY (1) CY1110337T1 (es)
DE (1) DE602005018965D1 (es)
DK (1) DK1831154T3 (es)
EA (3) EA015418B1 (es)
ES (1) ES2336014T3 (es)
GE (1) GEP20104895B (es)
HK (2) HK1104024A1 (es)
HR (1) HRP20100054T1 (es)
IL (1) IL179614A0 (es)
MA (1) MA28674B1 (es)
ME (1) ME01067B (es)
MX (1) MXPA06014228A (es)
NO (1) NO338097B1 (es)
NZ (1) NZ552220A (es)
PL (1) PL1831154T3 (es)
PT (1) PT1831154E (es)
RS (1) RS51210B (es)
SI (1) SI1831154T1 (es)
TW (6) TWI402248B (es)
UA (1) UA83575C2 (es)
WO (1) WO2006000904A2 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
EP1866275A1 (en) 2005-04-06 2007-12-19 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
US7488846B2 (en) 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
EP1768950A2 (en) * 2005-04-11 2007-04-04 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
US20070043241A1 (en) 2005-05-10 2007-02-22 Lilach Hedvati Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid
KR20070067077A (ko) 2005-05-10 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이소부틸글루타르산을 함유하지 않는 프레가발린 및 이의제조 방법
EP1879851B1 (en) 2005-05-10 2010-11-03 Teva Pharmaceutical Industries Ltd Method for the preparation of pregabalin and salts thereof
CZ297970B6 (cs) * 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
WO2007035890A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
US7462738B2 (en) 2006-05-24 2008-12-09 Teva Pharmaceutical Industries Ltd. Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
WO2007143152A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
KR20080036060A (ko) * 2006-05-31 2008-04-24 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법
WO2008118427A2 (en) 2007-03-22 2008-10-02 Teva Pharmaceutical Industries Ltd. Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
EP1992609A1 (en) * 2007-05-14 2008-11-19 Dipharma Francis S.r.l. A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性２−アルキル−１，１，３−トリアルコキシカルボニルプロパンの製造方法
KR100846419B1 (ko) * 2007-08-10 2008-07-15 한국과학기술원 프레가발린의 신규한 제조 방법
US20090062393A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched pregabalin
WO2009046309A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
ITMI20072262A1 (it) * 2007-12-03 2009-06-04 Dipharma Francis Srl Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico
US20100312010A1 (en) * 2007-12-18 2010-12-09 Watson Pharma Private Limited Process for the Preparation of (S)-Pregabalin
US20100324139A1 (en) * 2007-12-26 2010-12-23 Generics [Uk] Limited Process to pregabalin
SG176464A1 (en) * 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
EP2294207B1 (en) * 2008-05-21 2012-09-26 Sandoz AG Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
US20090312560A1 (en) * 2008-06-10 2009-12-17 Lambertus Thijs Processes for making pregabalin and intermediates therefor
WO2009158343A1 (en) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
WO2010070593A2 (en) 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Malonate esters
IT1394292B1 (it) 2009-05-07 2012-06-06 Dipharma Francis Srl Procedimento per la sintesi di pregabalina
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012025861A1 (en) 2010-08-23 2012-03-01 Pfizer Manufacturing Ireland Process for the preparation of ( s ) - 3 - cyano - 5 - methylhexanoic acid derivatives adn of pregabalin
WO2012059797A1 (en) * 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin
KR101306585B1 (ko) * 2011-04-14 2013-09-10 한국외국어대학교 연구산학협력단 프레가발린의 제조방법
CN102952057B (zh) * 2012-11-07 2015-09-09 浙江普洛家园药业有限公司 一种4-异丁基吡咯烷-2-酮的制备方法
JP6225490B2 (ja) * 2013-05-31 2017-11-08 大日本印刷株式会社 医薬品包装体
US10076550B2 (en) * 2014-06-25 2018-09-18 Council Of Scientific & Industrial Research Synergistic pharmaceutical composition for gastroinestinal disorders
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
CN104557576B (zh) * 2014-12-19 2019-07-19 浙江华海药业股份有限公司 一种高纯度普瑞巴林的制备方法
CN105348125A (zh) * 2015-11-26 2016-02-24 太仓运通生物化工有限公司 一种以异戊醛为原料合成普瑞巴林的方法
CN107445864B (zh) * 2017-08-09 2020-01-17 无锡殷达尼龙有限公司 一种纯化长碳链氰基酸产物的方法
CN108358799B (zh) * 2018-04-24 2020-11-10 贵州师范大学 一种普瑞巴林的制备方法
CN109503403B (zh) * 2018-12-21 2021-11-16 卓和药业集团股份有限公司 一种普瑞巴林的拆分方法
CN113248416B (zh) * 2020-02-10 2024-03-26 江西博腾药业有限公司 1-((苄氧基)羰基)-4-乙基吡咯烷-3-羧酸的制备方法及其应用
EP4103168A4 (en) * 2020-02-14 2024-04-24 Council Of Scientific & Industrial Research PROCESS FOR PREPARING GAMMA-AMINO-BUTYRIC ACIDS AND THEIR ANALOGS
CN111205288B (zh) 2020-02-19 2021-03-30 四川大学 一种(1S,12bS)内酰胺酯化合物的合成方法
CN113651717B (zh) * 2021-08-05 2024-08-30 浙江工业大学 一种光学纯异丁基丁二腈的消旋方法
CN113880724A (zh) * 2021-12-06 2022-01-04 南京桦冠生物技术有限公司 一种3-(2-氨基苯基)-2-丙烯酸酯的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125583A (en) * 1964-03-17 Hjnc oxchaxohxchc o oh
US637767A (en) * 1899-09-25 1899-11-28 Gaylard W Denyes Grain-drill.
SU452196A1 (ru) * 1973-02-12 2001-09-20 Филиал Всесоюзного Научно-Исследовательского Химико-Фармацевтического Института Им. Серго Орджоникидзе СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ
JPS60338B2 (ja) * 1980-12-16 1985-01-07 日本新薬株式会社 酪酸誘導体の製法
US4428887A (en) * 1982-07-14 1984-01-31 Monsanto Company Method of producing mono-substituted terminal diesters
US5618710A (en) * 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
DE19623142A1 (de) * 1996-06-10 1997-12-11 Huels Chemische Werke Ag Enantiomerenangereicherte, durch einen tertiären Kohlenwasserstoffrest substituierte Malonsäuremonoester sowie deren Herstellung
IL126999A (en) * 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
JPH10245369A (ja) * 1997-03-03 1998-09-14 Ajinomoto Co Inc セリン誘導体の製造方法
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
AU9019198A (en) * 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
RU2143002C1 (ru) * 1997-12-24 1999-12-20 Акционерное общество открытого типа "Мосагроген" СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ
PL345340A1 (en) * 1998-07-09 2001-12-17 Warner Lambert Co Compositions comprising gaba analogs and caffeine
BR9911887A (pt) * 1998-07-09 2001-03-27 Warner Lambert Co Método para o tratamento da insÈnia
DK1121114T3 (da) * 1998-10-16 2007-04-10 Warner Lambert Co Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
AP1438A (en) * 2000-01-27 2005-05-23 Warner Lambert Co Asymmetric synthesis of pregabalin.
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6931007B2 (en) * 2001-07-25 2005-08-16 Longboard, Inc. System and method of serving data messages
EP1333087A1 (en) * 2002-02-05 2003-08-06 Avantium International B.V. Crosslinked enzyme aggregates and crosslinking agent therefore
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
FR2849024B1 (fr) * 2002-12-20 2007-11-02 Aventis Pharma Sa Nouveaux composes chiraux derives d'esters de l'acide hexanoique, procede et intermediaires de preparation, utilisation a la synthese de l'acide 2-(bromomethyl)2-ethyl hexanoique chiral
JP2006061112A (ja) * 2004-08-30 2006-03-09 Sumitomo Chemical Co Ltd 光学活性な２−（シクロペンチルメチル）−マロン酸モノエステルの製造方法
KR20080036060A (ko) * 2006-05-31 2008-04-24 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법

Also Published As

Publication number Publication date
WO2006000904A2 (en) 2006-01-05
TW200846474A (en) 2008-12-01
NO20065329L (no) 2006-12-19
CA2571040C (en) 2009-09-15
CN1972904A (zh) 2007-05-30
US8134023B2 (en) 2012-03-13
MA28674B1 (fr) 2007-06-01
HRP20100054T1 (hr) 2010-05-31
TW200846307A (en) 2008-12-01
NZ552220A (en) 2010-08-27
TWI405747B (zh) 2013-08-21
EA200602099A1 (ru) 2007-04-27
AP2466A (en) 2012-09-17
EP1831154B1 (en) 2010-01-13
EP1831154A2 (en) 2007-09-12
CN102102114A (zh) 2011-06-22
AU2005256945B2 (en) 2008-11-13
US20120015412A1 (en) 2012-01-19
JP4966183B2 (ja) 2012-07-04
ME01067B (me) 2012-10-20
DE602005018965D1 (de) 2010-03-04
HK1161307A1 (en) 2012-08-24
EA200800909A1 (ru) 2008-08-29
KR20080015153A (ko) 2008-02-18
EA015418B1 (ru) 2011-08-30
CA2571040A1 (en) 2006-01-05
ATE455093T1 (de) 2010-01-15
KR100847929B1 (ko) 2008-07-22
JP4782101B2 (ja) 2011-09-28
AU2005256945A1 (en) 2006-01-05
TWI357405B (en) 2012-02-01
AP2006003846A0 (en) 2006-12-31
JP2008110985A (ja) 2008-05-15
BRPI0512347B8 (pt) 2021-05-25
CN1972904B (zh) 2011-02-02
SI1831154T1 (sl) 2010-03-31
DK1831154T3 (da) 2010-04-12
CR8765A (es) 2008-01-02
JP2008504252A (ja) 2008-02-14
GEP20104895B (en) 2010-02-25
RS51210B (sr) 2010-12-31
JP4800346B2 (ja) 2011-10-26
EA200800908A1 (ru) 2008-12-30
TW200900375A (en) 2009-01-01
KR20080015524A (ko) 2008-02-19
TW200846306A (en) 2008-12-01
EA011765B1 (ru) 2009-06-30
US20050283023A1 (en) 2005-12-22
NO338097B1 (no) 2016-08-01
BRPI0512347B1 (pt) 2018-03-20
US8044227B2 (en) 2011-10-25
US20110065168A1 (en) 2011-03-17
CN102102114B (zh) 2013-08-14
PT1831154E (pt) 2010-02-19
KR20080015152A (ko) 2008-02-18
HK1104024A1 (en) 2008-01-04
MXPA06014228A (es) 2007-02-14
IL179614A0 (en) 2007-05-15
TW200604139A (en) 2006-02-01
CY1110337T1 (el) 2015-01-14
UA83575C2 (uk) 2008-07-25
KR100847927B1 (ko) 2008-07-22
JP2008088191A (ja) 2008-04-17
US7838686B2 (en) 2010-11-23
PL1831154T3 (pl) 2010-05-31
JP2009022272A (ja) 2009-02-05
JP4174551B2 (ja) 2008-11-05
WO2006000904A3 (en) 2006-04-27
BRPI0512347A (pt) 2008-03-04
JP2008133289A (ja) 2008-06-12
TW200902481A (en) 2009-01-16
ES2336014T3 (es) 2010-04-07
TWI396743B (zh) 2013-05-21
TWI399361B (zh) 2013-06-21
JP4777332B2 (ja) 2011-09-21
US20090042262A1 (en) 2009-02-12
KR100847928B1 (ko) 2008-07-22
TWI402248B (zh) 2013-07-21
TWI377191B (en) 2012-11-21
CR20110483A (es) 2011-10-24

Similar Documents

Publication Publication Date Title
AR049446A1 (es) Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados
AR044874A1 (es) Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
PH12014502866A1 (en) Fungicidal heterocyclic carboxamides
CO6331462A2 (es) Compuesto de fenil pirrol o una sal farmaceuticamente aceptable del mismo con actividad activadora de la glucoquinasa
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AR047098A1 (es) Derivados de arilanilina como agonistas del receptor adrenergico beta2
CO5580815A2 (es) Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen
CR10034A (es) Derivados de oxadiazol
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR047085A1 (es) Derivados de (3-oxo-3,4-dihidro-quinoxalina-2-il-amino)benzamida y compuestos relacionados como inhibidores de glucogeno fosforilasa para el tratamiento de diabetes y obesidad
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
AR043436A1 (es) Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
PE20121047A1 (es) Derivados de tiazolilpiperidina como fungicidas
AR046085A1 (es) Agonistas etilamino amino sustituidos del receptor beta 2 adrenergico
CO5631432A2 (es) Derivados de n-[fenil(piepidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
AR060604A1 (es) Nuevos arilamino n- heteroarilos como inhibidores de mek
AR067412A1 (es) Moduladores de propiedades farmaceuticas de productos terapeuticos
JP2012512863A5 (es)
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
MY165634A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
AR060962A1 (es) Proceso de preparacion de derivados de quinazolina e intermediarios de sintesis
BR112013015604A2 (pt) novo derivado de isoquinolina substituído
AR040570A1 (es) Deriados de acilaminotiazol, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FG Grant, registration